failures – Pharma GMP

Case Studies: Failures in Uniformity of Dosage Units and CAPA

digi — Wed, 26 Nov 2025 03:45:04 +0000

Case Studies: Failures in Uniformity of Dosage Units and CAPA Step-by-Step Tutorial Guide: Managing Failures in Uniformity of Dosage Units in Process Controls and Implementing Effective CAPA Ensuring the uniformity of dosage units in process controls is a fundamental requirement for pharmaceutical manufacturing. Uniformity is essential to confirm that each dosage unit contains the intended...

Case Studies: Hold Time Failures and Their Impact on Batch Disposition

digi — Tue, 25 Nov 2025 17:33:04 +0000

Case Studies: Hold Time Failures and Their Impact on Batch Disposition Case Studies: Hold Time Failures and Their Impact on Batch Disposition In pharmaceutical manufacturing, hold time studies for bulk products and intermediates are critical components of Good Manufacturing Practice (GMP) compliance. These studies establish scientifically justified timeframes during which materials can be safely held...

Case Studies: Coating Process Failures and Their Regulatory Impact

digi — Tue, 25 Nov 2025 16:45:04 +0000

Case Studies: Coating Process Failures and Their Regulatory Impact Coating Process Failures: Regulatory Lessons and Controls in Pharmaceutical Manufacturing The coating process in pharmaceutical manufacturing is a critical step that significantly impacts the drug product’s quality, stability, and patient acceptability. Ensuring robust coating process controls in pharmaceutical manufacturing is essential to avoid failures such as...

Inspection Experiences: Aseptic Processing Failures and 483 Observations

digi — Tue, 25 Nov 2025 16:33:04 +0000

Inspection Experiences: Aseptic Processing Failures and 483 Observations Step-by-Step Tutorial on Avoiding Aseptic Processing Failures and FDA 483 Observations in Sterile Manufacturing Aseptic processing controls in sterile manufacturing are fundamental to ensuring patient safety and product efficacy. Regulatory agencies such as the FDA, EMA, and MHRA have stringent expectations to mitigate contamination events and maintain...

Common Blending Failures and Impact on Finished Product QC

digi — Tue, 25 Nov 2025 15:54:04 +0000

Common Blending Failures and Impact on Finished Product QC Step-by-Step Tutorial on Understanding and Managing Blending Failures in Pharmaceutical Manufacturing Effective blending controls to ensure content uniformity are critical for manufacturing consistent, safe, and efficacious pharmaceutical products. Yet, common failures during the blending process—such as segregation, dead spots, and under-mixing—can jeopardize product quality, leading to...

Case Studies: Cleaning Verification Failures and Impact on Manufacturing

digi — Tue, 25 Nov 2025 14:24:04 +0000

Case Studies: Cleaning Verification Failures and Impact on Manufacturing Case Studies on Cleaning Verification Failures and Their Impact on Pharmaceutical Manufacturing Cleaning verification testing by QC (Quality Control) is a critical element in pharmaceutical manufacturing to ensure product quality, patient safety, and regulatory compliance. Failures in cleaning verification can lead to significant operational impacts, including...

Handling Method Transfer Failures and Discrepant Results

digi — Tue, 25 Nov 2025 13:36:04 +0000

Handling Method Transfer Failures and Discrepant Results Step-by-Step Tutorial on Handling Method Transfer Failures and Discrepant Results The analytical method transfer between R&D and QC laboratories is a critical phase in pharmaceutical product development and manufacturing. It ensures that an analytical procedure developed under controlled research conditions can be consistently and reliably performed in the...

Case Studies: Sterility and Endotoxin Failures in QC Labs

digi — Tue, 25 Nov 2025 12:51:04 +0000

Case Studies: Sterility and Endotoxin Failures in QC Labs Analyzing Sterility Testing and Endotoxin Failures in QC Laboratories: A Step-by-Step Guide Ensuring product sterility and controlling endotoxin levels are critical responsibilities of pharmaceutical quality control (QC) laboratories. Failures in sterility testing in QC laboratory settings often lead to significant regulatory scrutiny, product recalls, and manufacturing...

Case Studies: Sterility and Endotoxin Failures in QC Labs

digi — Tue, 25 Nov 2025 12:51:04 +0000

Case Studies: Sterility and Endotoxin Failures in QC Labs In-Depth Case Studies on Sterility and Endotoxin Failures in QC Laboratories Sterility testing in QC laboratory environments remains a cornerstone of ensuring pharmaceutical product safety and compliance with regulatory requirements. Despite rigorous controls, contamination events and endotoxin test failures continue to pose significant risks that can...

Case Studies: Stability QC Failures and Regulatory Impact

digi — Tue, 25 Nov 2025 10:51:04 +0000

Case Studies: Stability QC Failures and Regulatory Impact Understanding the Role of QC Laboratory in Stability Testing: Case Studies on Failures and Regulatory Consequences The stability of pharmaceutical products over their shelf life critically affects their safety and efficacy. The role of QC laboratory in stability testing is pivotal to ensuring that drug products meet...